Phenoxybenzamine Hydrochloride Capsule
Product Images NDC 60219-1502

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Phenoxybenzamine Hydrochloride (NDC 60219-1502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Phenoxybenzamine Hydrochloride Capsules Usp 10 mg 1)

FDA Label Image

1 (Phenoxybenzamine Hydrochloride Capsules Usp 10 mg 2)

1 (Phenoxybenzamine Hydrochloride Capsules Usp 10 mg 2)
Phenoxybenzamine Hydrochloride Capsules are an oral solid dosage unit used to treat high blood pressure and sweating caused by pheochromocytoma. Each capsule contains 10mg of Phenoxybenzamine Hydrochloride, USP. The usual dosage should be determined by a healthcare provider. The product should be stored at temperatures between 20° to 25°C, and should be dispensed in a tight container as defined in the USP. The manufacturer is Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India, and it is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The NDC number for this product is 60219-1502-1.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.